• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Migraine Headache - Myth vs Facts

Slideshow

There is a good deal of misinformation available about migraine headaches. Which of these 10 statements are myth and which are fact?

  

Recent Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
Migraine-specific therapies belong in primary care setting, Jessica Ailani, MD
Related Content
Novel DHE Nasal Spray for Acute Treatment of Migraine: Daily Dose / image credit: ©New Africa/AdobeStock

Novel DHE Nasal Spray for Acute Treatment of Migraine: Daily Dose

Sydney Jennings
October 29th 2024
Article

Your daily dose of the clinical news you may have missed.

Gepants for Migraine Prevention: A Perfect Fit for Primary Care

Gepants for Migraine Prevention: A Perfect Fit for Primary Care

Sydney Jennings
March 30th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with headache specialist Peter McAllister, MD.

Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial / image credit migraine concept: ©Mobic/Shutterstock.com

Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial

Grace Halsey
October 15th 2024
Article

Use of the unique STS101 drug device combination proved safe, well tolerated, and effective with as needed use over 12 months, reported Satsuma Pharmaceuticals.

Primary Viewpoints Episode 1: COVID-19 Impact on Migraine Management

Primary Viewpoints Episode 1: COVID-19 Impact on Migraine Management

Sydney Jennings
July 20th 2020
Podcast

In episode 1 of Primary Viewpoints, migraine specialist Peter McAllister, MD, discusses how the COVID-19 pandemic has impacted his migraine patients.

Erenumab Induces Remission in Chronic Migraine Medication Overuse Headache / image credit migraine concept: ©

Erenumab Induces Remission in Chronic Migraine Medication Overuse Headache

Grace Halsey
September 20th 2024
Article

Erenumab 140 mg safely and effectively induced remission in nonopioid MOH within 6 months in individuals for whom other preventive medications had failed.

Investigational PACAP Inhibitor Reduces Monthly Migraine Days, Lundbeck Reports / image credit stop headache concept: ©jiris/stock.adobe.com

Investigational PACAP Inhibitor Reduces Monthly Migraine Days, Lundbeck Reports

Grace Halsey
September 16th 2024
Article

Individuals with migraine who failed to respond to up to 4 previous migraine preventive treatments saw fewer monthly migraine and headache days after 1 infusion of Lu AG90222.

© 2024 MJH Life Sciences

All rights reserved.